首页> 外文期刊>Journal of pharmacology & toxicology. >Hypoglycaemic and Antihyperglycaemic Effect of Syzygium cumini Bark in Streptozotocin-Induced Diabetic Rats
【24h】

Hypoglycaemic and Antihyperglycaemic Effect of Syzygium cumini Bark in Streptozotocin-Induced Diabetic Rats

机译:Syzygium cumini Bark在链脲佐菌素诱导的糖尿病大鼠中的低血糖和抗血糖作用

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to investigate the hypoglycaemic and antihyperglycaemic effect of Syzygium cumini (S. cumini) bark in diabetic rats. Diabetes was induced in male albino Wistar rats by a single intraperitoneal injection of streptozotocin (45 mg kg"' body weight). An aqueous extract of S. cumini bark (SBEt) was administered orally (75,150 and 300 mg kg body weight) for 45 days and changes in blood glucose, urine sugar, food and fluid intakes and body weight were examined in diabetic rats. Glibenclamide was used as a standard reference drug. The levels of blood glucose and urine sugar were increased significantly in diabetic rats. Oral administration of SBEt to diabetic rats led to significantly decreased levels of blood glucose and urine sugar.
机译:本研究的目的是探讨Syzygium Cumini(Sumumi)在糖尿病大鼠中的低血糖和抗血糖作用。 通过单一腹腔注射链脲佐菌素(45mg kg“体重)诱导糖尿病患者。口服(75,150和300mg体重)施用S. Cumini Bark(SBET)的水性提取物45 在糖尿病大鼠中检查了血糖,尿糖,食物和流体摄入和体重的日子和变化。Glibenclamide用作标准参考药物。糖尿病大鼠血糖和尿糖水平显着增加。口服给药 糖尿病大鼠的SBET导致血糖和尿糖水平显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号